2705, boulevard Laurier
A-1602
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Ernst, MélanieEmployéCHUL+1 418-525-4444, poste 47044Melanie.Ernst@crchudequebec.ulaval.ca
2705, boulevard Laurier
A-1602
Québec, Québec
Canada G1V 4G2 - Giannakouros, PanagiotaEmployéCHUL+1 418-525-4444, poste 40192Panagiota.Giannak@crchudequebec.ulaval.ca
2705 Boulevard Laurier
A-0121
Québec, QC
Canada G1V 4G2
Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes
Article de revueJ Med Genet, 2023.
Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors
Article de revueNeurooncol Adv, 5 (1), 2023.
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study
Article de revueJ Clin Oncol, 41 (10), 2023.
Upfront BRAF/MEK inhibitors for treatment of high-grade glioma: A case report and review of the literature
Article de revueNeurooncol Adv, 4 (1), 2022.
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas
Article de revueNat Genet, 54 (12), 2022.
Durable Response to Trametinib in an Infant With ERC1-BRAF Infantile Fibrosarcoma-Like Tumor: A Case Report and Literature Review of BRAF-Altered Infantile Fibrosarcoma-Like Tumors
Article de revueJCO Precis Oncol, 6 , 2022.
Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real-world case series
Article de revuePediatr Blood Cancer, 69 (8), 2022.
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Article de revueNat Med, 28 (1), 2022.
Incidence of childhood cancer in Canada during the COVID-19 pandemic
Article de revueCMAJ, 193 (47), 2021.
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes
Article de revueJAMA Oncol, 7 (12), 2021.
Projets actifs
- A Phase 2 study of Trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathwa, du 2019-04-01 au 2024-09-30
- Phase III randomized double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients, du 2022-06-21 au 2027-12-25
- Subvention pour la recherche clinique, du 2008-04-01 au 2024-03-31